Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001079845 | SCV000645284 | likely benign | Amyotrophic lateral sclerosis type 4; Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-10-29 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics Inc | RCV000542634 | SCV001145575 | benign | not provided | 2018-09-18 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233731 | SCV003931572 | likely benign | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 2 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003233732 | SCV003931573 | likely benign | Amyotrophic lateral sclerosis type 4 | 2023-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925661 | SCV004740350 | likely benign | SETX-related condition | 2019-02-19 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Laboratory of Diagnostic Genome Analysis, |
RCV000542634 | SCV001799979 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000542634 | SCV001807648 | likely benign | not provided | no assertion criteria provided | clinical testing |